CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 30 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $596,000 | -36.1% | 2,590,613 | 0.0% | 0.00% | – |
Q4 2017 | $933,000 | -27.7% | 2,590,613 | +4.3% | 0.00% | – |
Q3 2017 | $1,291,000 | -7.8% | 2,483,584 | +2.9% | 0.00% | – |
Q2 2017 | $1,400,000 | -61.4% | 2,414,475 | +17.9% | 0.00% | – |
Q1 2017 | $3,626,000 | +62.5% | 2,048,283 | +10.2% | 0.00% | – |
Q4 2016 | $2,231,000 | +125.6% | 1,858,649 | +101.1% | 0.00% | – |
Q3 2016 | $989,000 | +3.9% | 924,384 | +1.0% | 0.00% | – |
Q2 2016 | $952,000 | -6.6% | 915,369 | +8.7% | 0.00% | – |
Q1 2016 | $1,019,000 | -11.2% | 842,234 | +13.0% | 0.00% | – |
Q4 2015 | $1,148,000 | -99.3% | 745,443 | -86.5% | 0.00% | -100.0% |
Q3 2015 | $160,943,000 | +9761.7% | 5,507,340 | +1614.1% | 0.01% | – |
Q2 2015 | $1,632,000 | – | 321,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prospera Financial Services Inc | 176,100 | $287,000 | 0.05% |
RFG Advisory, LLC | 40,000 | $65,000 | 0.05% |
Acrospire Investment Management LLC | 16,551 | $29,000 | 0.02% |
HighTower Advisors, LLC | 1,047,731 | $1,854,000 | 0.02% |
B. Riley Wealth Advisors, Inc. | 25,958 | $46,000 | 0.01% |
EXENCIAL WEALTH ADVISORS, LLC | 11,900 | $19,000 | 0.01% |
THOMPSON DAVIS & CO., INC. | 3,000 | $5,000 | 0.01% |
LBA Wealth Management, LLC | 8,000 | $14,000 | 0.01% |
INGALLS & SNYDER LLC | 20,739 | $37,000 | 0.00% |
Vantage Investment Advisors, LLC | 1,150 | $2,000 | 0.00% |